4//SEC Filing
Kathiresan Sekar 4
Accession 0001864112-25-000004
CIK 0001842295other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:16 PM ET
Size
5.6 KB
Accession
0001864112-25-000004
Insider Transaction Report
Form 4
Kathiresan Sekar
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 totalExercise: $23.67Exp: 2035-09-21→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
Documents
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeother
Related Parties
1- filerCIK 0001864112
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:16 PM ET
- Size
- 5.6 KB